Increasing Efficiency in the Healthcare Supply Chain through NEHTA

Increasing Efficiency in the
Healthcare Suppl y Chain
through NEHTA
Maria Palazzolo
CEO
© GS1 Australia 2012-13
Agenda
• Australia’s healthcare system
• GS1 Australia in healthcare
• Introducing the National E -Health Transition Authorit y
• The NEHTA Supply Chain Program and GS1 standards
• The Future Direction
© GS1 Australia 2012-13
2
Australia
•
•
•
•
•
In land area, is estimated to be
7,692,024 square km
Sixth largest nation after
Russia, Canada, China, the
United States of America and
Brazil
23 million people currently live
in Australia
64% of people live in capital
cities
36% live in regional Australia,
approximately 8.28 million
Source: About Australia; http://www.about-australia.com/facts/
© GS1 Australia 2012-13
3
Australia’s Healthcare Environment
• Life expectancy continues to increase, so an Australian male born
today can expect to live to 79.2 years and a female to 83.7 years
• Australians aged 80 years or over is about 800,000 (3.7% of the total
population); nearly 2/3 are female
• Healthcare is funded from multiple sources
• 70% is publically funded & 30% privately funded
• 8 State & Territory Governments (State Health Departments) and
Federal Department of Health and Ageing
• Healthcare provision is cost ly and complex – expenses are growing
• Expenditure on health was 9.1% of GDP in 2007–08, amounting to
over $103 billion or $4,874 per person
• In 2009-10 this increased to $121.4 billion, or 9.4% of the GDP
Source: Australian Institute of Health and Welfare;
http://aihw.gov.au/WorkArea/DownloadAsset.aspx?id=6442452951 and http://www.aihw.gov.au/publicationdetail/?id=10737420435
© GS1 Australia 2012-13
4
GS1 Australia
• Serving Australian Industry for 35
years
• Over 17,500 members across 21
industry verticals
• Enabling implementation through
industry services like, NPC, GS1
Recallnet, GS1 Locatenet, GS1
GoScan and many others
• Engaged with Australian healthcare
sector for 10+ years
© GS1 Australia 2012-13
GS1 Healthcare User Group
Australasia
• Second local User Group, formed in 2006
• Monthly leadership teleconf erences
• 2 industry wide face to face meetings per annum – Australia
& New Zealand
• Active engagement with Solution Providers
© GS1 Australia 2012-13
6
Industry Driving Direction
GS1 Healthcare User Group Australasia Leadership T eam
•
•
•
•
•
•
•
•
•
•
Lyn Cormack, Tender and Contracts Manager – Health Care, 3M Australia Pty Ltd
Dianne Prince, Customer Supply Chain Manager, Abbvie Pty Ltd
Chris Parkinson, ANZ Supply Chain Manager, Braun Australia Group
Ged Halstead (Co-Chair), Chief Information Officer, Clifford Hallam Healthcare (CH2)
Valentino Bulaon, Manager, Catalogue & Procurement Information, HealthShare NSW
Health
Eva Chow, IT Director, Medtronic Australasia
Mark Brommeyer, Manager Supply Chain, National E-Health Transition Authority (NEHTA)
Robert Baxter, Operations Director, Smith and Nephew Advanced Surgical Division
Matt Malone, Chief Information Officer, Symbion Pharmacy Services
Yvonne Bell (Co-Chair), National Business Support Manager, Terumo Australia Pty Limited
© GS1 Australia 2012-13
7
NEHTA
The National E-Health Transition Authority (NEHT A)
is a company established by the Australian, State and Territory
governments in 2005 to develop better ways of electronically
collecting and securely exchanging health information.
Independent company – state and federally government f unded,
including:
•
•
•
•
•
Board of Directors (CEOs of Health Jurisdictions, an Independent Director
and an Independent Chair)
Board Committees
The Chief Executive Officer
The Company Secretary
The NEHTA Organisation
© GS1 Australia 2012-13
Source: NEHTA
8
Healthcare supply chain reform
Supply Chain Reform needed because:
1. Lack of standardised product identification
2. Lack of standardised location identification
3. Multiple product data catalogues being maintained per hospital, per
hospital network and per state
Poor supply chain costs the health system money:
• Wrong product ordered/del ivered
• Wrong quantity/poor forecasting and inventory management
Automating processes enables supplier and buyer organisations to:
• Reduce redundant purchasing tasks
• Improve inefficient work practices
• Achieve greater accuracy in procurement and tendering
© GS1 Australia 2012-13
Source: NEHTA
9
Healthcare Supply Chain Reform
Accurate Data is Critical
eHealth Supply Chain Ref orm can deliver:
þ The right
þ The right
þ The right
þ The right
þ The right
© GS1 Australia 2012-13
products, at
price, for
person, in
location, at
time
Source: NEHTA
10
NEHTA – Leveraging GS1 Standards
NEHTA chose to assess current market direction and leverage existing standards
rather than creating Australian specific solutions. As a result Australian Healthcare
supply chain reform is based on the GS1 s tandards .
Program Component
GS1 Standards
Product Identification
Global Trade Item Number
Location Identification
Global Location Number
National Product Catalogue
Global Data Synchronisation Network
NEHTA eProcurement Solution
GS1 XML
Location Number Directory
GS1 Australia’s Locatenet Service
Electronic Recall Notification Solution
GS1 Australia’s Recallnet
© GS1 Australia 2012-13
11
The National Product Catalogue
•
•
•
The National Product Catalogue (NPC) is a way for suppliers to provide
standardised and accurate product and price data electronically to the
Australian health departments and private hospital providers.
The NPC provides suppliers with a single mechanism to communicate
structured catalogue data to many health customers – and the health
customers a single way to access this data from multiple suppliers.
The NPC enables synchronisation of product and pricing data for accuracy
in electronic procurement.
© GS1 Australia 2012-13
Source: NEHTA
NPC Value and Use Cases
© GS1 Australia 2012-13
13
NPC – Data Synchronisation
Source: NEHTA
14
Product data is common to all - Price data is customer specific
© GS1 Australia 2012-13
National E-Health Transition Authority
www.nehta.gov.au
NPC Data Usage
• The NPC contains 314, 000+ GTIN records
• More records are being added each month
• More than 430 suppliers provide data to the NPC
• 25+ data recipients use the NPC data
• All public health jurisdictions
• Major private sector buyers
• Wholesalers and distributors
Recent Healthcare Data Crunch report findings:- “By conservative
estimates, more than $100 million in potential savings can be achieved by
addressing product data quality issues” The report also “identifiies the
benefits to all parts of the supply chain by bringing healthcare product data
quality up to best practice” “Using the NPC takes 10% of manual order
errors to less than 1%”
Source: Healthcare Data Crunch Report :
Nehta, RMIT University, Medical Technology (MTAA ) ,GS1 Australia
© GS1 Australia 2012-13
15
GS1 Locatenet for Healthcare
More than 2500 GLNs loaded and
increasing with automated loading
processes being enabled
GLNs are needed for identification of:
•
•
•
•
Data source and data recipient in the
NPC
Price location in the NPC
Physical locations for logistics
movement
Sender and receiver for electronic
messaging
© GS1 Australia 2012-13
Healthcare Recallnet – The Project
Project Need
•
•
•
Product recalls have a large impact on all involved
Product recalls are increasing
Opportunities exist to improve the product recall process through new
technologies, data standards and a more streamlined process
Project Mission
To deliver an electronic product recall notification system in the Australian
healthcare sector, through a phased approach, to improve the speed and
accuracy of the therapeutic goods recall process with the aim of improving
patient safety.
NPC is key to standard data and a shared identifier across all parties GS1
Product Number (GTIN) and Locat ion Number (GLN)
© GS1 Australia 2012-13
Source: NEHTA
GS1 Recallnet Value and Use Cases
© GS1 Australia 2012-13
18
GS1 Recallnet – Healthcare Therapeutic Recall &
Non-Recall Action Notification Process
TGA Recall Notice
Please note: The term “Recall” is used in these slides to
refer to both Recall and Non Recall Actions as defined in
the Uniform Recall Procedure for Therapeutic Goods
6
TGA assesses the notification, proposed recall
strategy, customer communication and the
required information submitted by the
sponsor. Based on this assessment, TGA will
provide comments to the sponsor and if the
proposed recall strategy and customer
communication are acceptable, will agree to the
recall and issue a TGA Reference ID. This
communication happens outside of GS1
Recallnet Healthcare
Recall Receivers
TGA
Agreement
TGA Ref ID
6
Recall Coordinator
State Health
Departments
TGA
CHO Office
Central Warehousing
LHN CEO
Local Heath
Network s /
Districts
LHN Chief Pharmacist
LHN BiopMed Engineer
Hosp. CEO
Hospitals
Hosp. Chief Pharmacist
Hosp. BiopMed Engineer
7
Nominated Rep.
Wholesalers
1
Create
Notification
2
Submit
Notification
3
Internal
Acceptance
4
TGA
Assessment
5
Go
Live
Nominated Rep.
Pharmacies
Initiator
Approver
RECALL SPONSOR
© GS1 Australia 2012-13
Approver
Approver
Approver
Nominated Rep
Nominated Rep
Nominated Rep.
Retailers
Nominated Rep
Physical Goods Marking
100%
Medicines
80%
60%
% No Code
40%
% Not GS1
20%
%GS1
0%
2003
2011
Year
%GS1
% Not GS1
% No Code
2003
73.12
0.31
26.57
2011
85.98
9.81
4.21
2013
97.05
1.11
1.85
2013
100%
Medical Devices
80%
60%
% No Code
40%
% Not GS1
20%
%GS1
0%
2003
Year
%GS1
% Not GS1
% No Code
2003
56.03
11.45
32.51
2011
57.35
10.04
32.62
2013
75.49
13.46
11.04
2011
2013
© GS1 Australia 2012-13
20
Linking the Medicines Concept to
the Physical Product
Australian Medicines Terminology (AMT)
• Developed to be fit for the purpose of unambiguously
identifying for clinicians and computer systems, commonly
used medicines in Australia and can be implemented in
clinical information systems for the following activities:
• Prescribe
• Record
• Review
• Issue – including dispense
• Administer
• Transfer of information
© GS1 Australia 2012-13
Source: NEHTA
21
Linking the Medicines Concept to
the Physical Product
Proposed Next Steps
1. Phase 1: Associate AMT identifier to GTIN – align with TGA
processes f or new medicines.
2. Phase 2: Associate AMT identifier to GTIN – existing
medicines on the NPC.
3. Phase 3: Enable interoperability between applications and
clinical information systems to deliver greater quality, safety
and efficiency of care in relation to medicines, e.g. bar code
scanning to the bedside.
© GS1 Australia 2012-13
Source: NEHTA
22
Ultimately, it’s all about…
PATIENT SAFETY!
© GS1 Australia 2012-13
23
Contact Details
Maria Palazzolo
CEO
GS1 Australia
+61 3 9558 9559
[email protected]
www.gs1au.org
© GS1 Australia 2012-13